Medco Research Extends Research

Medco Research Inc. of Los Angeles secured from the University of Virginia Alumni Patents Foundation an extension of its exclusive right to research, develop and market Adenocard for $200,000, according to a Securities and Exchange Commission filing.

Under the agreement, Medco has until March, 1992, to obtain Federal Drug Administration approval for Adenocard, an injectable acute treatment for supraventricular tachycardia.

Medco manufactures pharmaceuticals and medical devices.